Patient Satisfaction After Surgery for Otosclerosis Under Local ou General Anesthesia (SPOC)

April 4, 2022 updated by: Rennes University Hospital
Main purpose of this study is to compare comfort level of patients, after otosclerosis surgery, under local or general anesthesia.

Study Overview

Detailed Description

The care system will not differ from the usually treatment of patients. Patients will decided about the type of anesthesia (local or general) after detailed description of both procedures.

All operations will be performed by the same surgeon and the same basic surgical technique.

The only difference is that patients included in thi study will have to complete a satisfactory survey 10 days after surgery and a GBI questionnaire 3 months after surgery, during the post operative consultations .

Study Type

Observational

Enrollment (Actual)

103

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Rennes, France, 35033
        • Centre Hospitalier Universitaire de Rennes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients suffering from otosclerosis who have surgical indication

Description

Inclusion criteria:

  • Patients older than 18 years suffering from otosclerosis who have surgical indication.
  • Patients who want surgical treatment for their otosclerosis
  • Clinic : Deafness with social prejudice and normal otoscopic exam
  • Audiometric : conductive or mixed hearing loss with abolition of the aural reflex. Audiometric threshold more than 30decibel (dB) and air bone gap more important than 20dB.
  • Pré operative scan in favor of otosclerosis
  • Diagnosis confirmation during the surgery with stapes sclerotic's attachments to the oval window

Exclusion criteria:

  • History of ear surgery
  • No medical objection to local anesthesia
  • No medical objection to general anesthesia
  • No medical objection to ear surgery
  • No legal protection for adults
  • No participation refusal

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Local anesthetic
Patients who chose local anesthesia for their surgery
1% or 2% lidocaine with 1:100,000 epinephrine, augmented by intravenous sedation and analgesia
General anesthetic
Patients who chose general anesthesia for their surgery
Endotracheal intubation, intravenous narcotic agents, and inhaled agents

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual comfort scale (EVA type ruler)
Time Frame: 10 days after surgery
respondents specify their level of comfort during the surgery by indicating a position along a continuous line between two end-points : Minimum score is 0 (no comfort) and maximum is 10 (very comfortable) during surgery
10 days after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Glasgow Benefit Inventory questionnaire GBI
Time Frame: 3 months after surgery

Glasgow Benefit Inventory questionnaire GBI (GBI, Robinson et al. 1996).

  • The Glasgow Benefit Inventory (GBI) is a measure of patient benefit developed especially for otorhinolaryngological (ORL) interventions.

    18 items in 3 categories defined by social, psychological, and physical perceptions of well-being

  • Responses are based on a 5-point Likert scale, ranging from a large deterioration in health status (1) to a large improvement (5).
  • The total GBI score is then calculated from an average of the Likert scores to give equal weight to each question. The average (1 5) is subtracted by 3 (no change), and the result is multiplied by 50 to produce a GBI score that ranges from 100 (maximum detriment after surgery) to 100 (maximum improvement after the intervention). A GBI score of zero is neutral and indicates no improvement or detriment from the intervention.
3 months after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Benoit Godey, PH-PD, Rennes University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2019

Primary Completion (Actual)

March 3, 2021

Study Completion (Actual)

June 21, 2021

Study Registration Dates

First Submitted

February 4, 2019

First Submitted That Met QC Criteria

March 21, 2019

First Posted (Actual)

March 25, 2019

Study Record Updates

Last Update Posted (Actual)

April 5, 2022

Last Update Submitted That Met QC Criteria

April 4, 2022

Last Verified

March 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Otosclerosis

Clinical Trials on Local anesthetic

3
Subscribe